​

Allurion Stock (NYSE:ALUR)

ForecastRevenueFinancialsChartTranscripts
Allurion by TradingView

Previous Close

$0.34

52W Range

$0.30 - $4.00

50D Avg

$0.57

200D Avg

$1.21

Market Cap

$20.43M

Avg Vol (3M)

$395.13K

Beta

-0.41

Div Yield

-

ALUR Company Profile

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

501

IPO Date

Mar 29, 2021

Website

ALUR Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/ServiceSep 24Jun 24Mar 24
FRANCE$2.43M$1.87M$1.67M
AUSTRALIA$543.00K--
All Other Countries$3.35M$8.45M$5.35M
SPAIN$3.00M$1.45M$1.11M
ITALY$511.00K--

Fiscal year ends in Dec 23 | Currency in USD

ALUR Financial Summary

Dec 23Dec 22Dec 21
Revenue$53.47M$64.21M$38.24M
Operating Income$-79.08M$-32.01M$-12.50M
Net Income$-80.61M$-37.74M$-12.39M
EBITDA$-79.08M$-31.16M$-12.35M
Basic EPS$-2.27$-0.81$-0.27
Diluted EPS$-2.27$-0.81$-0.27

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts

Q3 24Nov 13, 24 | 12:43 PM
Q2 24Aug 13, 24 | 10:18 AM
Q1 24May 14, 24 | 11:58 AM